The global immunoassay market was valued at USD 28.05 billion in 2025 and is anticipated to reach USD 40.25 billion by 2033, expanding at a CAGR of 4.63% from 2026 to 2033. The market growth is primarily supported by the increasing demand for precision medicine and advanced diagnostic solutions across healthcare systems worldwide. Immunoassays have become an essential component in disease diagnosis and therapeutic monitoring because they enable the identification of biomarkers associated with specific diseases and treatment responses. The growing adoption of personalized healthcare approaches has significantly strengthened the role of immunoassay technologies in modern clinical diagnostics.

Key Market Trends & Insights

• The North America immunoassay industry held the largest share of 47.27% of the global market in 2025.
• The immunoassay industry in the U.S. is expected to grow significantly over the forecast period.
• By product, the reagents & kits segment held the highest market share of 66.22% in 2025.
• By technology, the enzyme immunoassays (EIA) segment held the largest market share in 2025.
• By application, the infectious disease segment held the largest market share in 2025.

Market Size & Forecast

• 2025 Market Size: USD 28.05 Billion
• 2033 Projected Market Size: USD 40.25 Billion
• CAGR (2026-2033): 4.63%
• North America: Largest market in 2025
• Asia Pacific: Fastest growing market

The increasing burden of chronic and infectious diseases has further accelerated the demand for immunoassay-based testing solutions. Diseases such as cancer, cardiovascular disorders, autoimmune conditions, and infectious diseases require accurate and early diagnosis for effective treatment planning. Immunoassays help healthcare professionals identify disease-specific biomarkers, which supports targeted therapies and improves clinical outcomes. The transition from generalized treatment approaches to patient-specific therapies has encouraged healthcare providers and pharmaceutical companies to rely more heavily on immunodiagnostic technologies.

Download a free sample copy of the Immunoassay Market report to understand detailed coverage and inclusions in the final report

Another major factor contributing to market expansion is the rapid advancement in laboratory automation and diagnostic technologies. Modern immunoassay systems are increasingly integrated with artificial intelligence, automation platforms, and digital healthcare infrastructure, improving testing efficiency and reducing turnaround time. These developments are helping laboratories manage high sample volumes while maintaining accuracy and consistency in diagnostic procedures. The growing preference for automated immunoassay analyzers in hospitals and diagnostic laboratories is expected to create strong opportunities for market growth over the forecast period.

The pharmaceutical and biotechnology sectors are also playing an important role in the expansion of the immunoassay industry. Pharmaceutical companies are utilizing immunoassays throughout drug discovery, clinical trials, and therapeutic monitoring processes. These assays assist in evaluating drug efficacy, monitoring patient response, and identifying suitable patient populations for targeted therapies. As a result, immunoassays are becoming increasingly important in the development of precision therapeutics and biologic drugs.

The market is also benefiting from increasing healthcare expenditure and expanding access to diagnostic services in emerging economies. Governments and healthcare organizations are investing in healthcare infrastructure and laboratory modernization, particularly in developing regions. Rising awareness regarding early disease detection and preventive healthcare has further increased the adoption of immunoassay testing in hospitals, diagnostic centers, and research institutions.

Looking for more specific insights? Customize this report to suite your business needs

Technological innovation remains one of the defining characteristics of the immunoassay market. Companies are focusing on the development of highly sensitive, rapid, and cost-effective diagnostic assays capable of detecting diseases at early stages. Innovations in chemiluminescence immunoassays, multiplex assays, and point-of-care testing technologies are improving diagnostic accuracy and accessibility. Point-of-care immunoassays are especially gaining traction due to their ability to deliver rapid results in decentralized healthcare settings, including clinics, emergency rooms, and home-care environments.

In addition, the growing importance of infectious disease surveillance has strengthened the demand for immunoassay technologies globally. The need for rapid and reliable testing during disease outbreaks has highlighted the significance of immunodiagnostics in public health management. Immunoassays continue to play a critical role in detecting viral, bacterial, and parasitic infections, enabling healthcare systems to respond more effectively to public health challenges.

Key Immunoassays Company Insights

Leading companies operating in the immunoassay industry, including Abbott, Siemens Healthineers, Danaher Corporation (Beckman Colter), bioMérieux, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories, Inc., Roche, Becton, Dickinson and Company, and Thermo Fisher Scientific, are continuously focusing on technological advancements and portfolio diversification to strengthen their market position. These organizations are actively investing in research and development activities to introduce innovative diagnostic solutions with enhanced accuracy, sensitivity, and automation capabilities.

Explore Grand View Horizon to see global and regional level statistics related to the Immunoassay Market

Companies are increasingly adopting strategic initiatives such as mergers and acquisitions, collaborations, partnerships, product launches, and regional expansion strategies to increase their global presence and improve market competitiveness. The growing emphasis on point-of-care testing, biomarker discovery, and AI-enabled laboratory systems is creating opportunities for companies to expand their immunodiagnostic capabilities and address evolving healthcare demands.

The competitive landscape of the immunoassay market is characterized by strong innovation and continuous product development. Market participants are focusing on automated immunoassay analyzers and multiplex testing platforms that can improve workflow efficiency and support high-throughput diagnostic testing. In addition, the integration of digital healthcare technologies and cloud-based laboratory management systems is further transforming the operational efficiency of immunodiagnostic laboratories.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Key Immunoassays Companies:

• Abbott
• Siemens Healthineers
• Danaher Corporation (Beckman Coulter)
• bioMérieux SA
• Quidel Corporation
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche AG
• Becton, Dickinson, and Company
• Thermo Fisher Scientific, Inc.

Conclusion

The global immunoassay market is witnessing stable growth due to the increasing demand for precision medicine, early disease detection, and advanced diagnostic technologies. Rising prevalence of chronic and infectious diseases, coupled with the growing adoption of personalized treatment approaches, continues to drive the demand for immunoassay-based testing solutions worldwide. Technological advancements in automation, artificial intelligence, and point-of-care diagnostics are further enhancing the efficiency and accessibility of immunodiagnostic systems. In addition, expanding healthcare infrastructure, increasing pharmaceutical research activities, and strong investments in biomarker-based diagnostics are expected to create long-term growth opportunities for industry participants. With North America maintaining market leadership and Asia Pacific emerging as the fastest growing region, the immunoassay industry is projected to experience sustained expansion through 2033.

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…

Browse our new services – Grand View Brainshare